GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixinol Wellness Ltd (ASX:EXL) » Definitions » Cash Flow from Financing

Elixinol Wellness (ASX:EXL) Cash Flow from Financing : A$1.61 Mil (TTM As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Elixinol Wellness Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Dec. 2023, Elixinol Wellness paid A$0.00 Mil more to buy back shares than it received from issuing new shares. It received A$0.00 Mil from issuing more debt. It paid A$0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received A$0.00 Mil from paying cash dividends to shareholders. It received A$0.00 Mil on other financial activities. In all, Elixinol Wellness spent A$0.00 Mil on financial activities for the six months ended in Dec. 2023.


Elixinol Wellness Cash Flow from Financing Historical Data

The historical data trend for Elixinol Wellness's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elixinol Wellness Cash Flow from Financing Chart

Elixinol Wellness Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Financing
Get a 7-Day Free Trial 46.44 27.55 -1.16 -0.76 1.61

Elixinol Wellness Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.55 -0.39 -0.37 1.71 -0.10

Elixinol Wellness Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Elixinol Wellness's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

Elixinol Wellness's Cash from Financing for the quarter that ended in Dec. 2023 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$1.61 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elixinol Wellness  (ASX:EXL) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Elixinol Wellness's issuance of stock for the six months ended in Dec. 2023 was A$0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Elixinol Wellness's repurchase of stock for the six months ended in Dec. 2023 was A$0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Elixinol Wellness's net issuance of debt for the six months ended in Dec. 2023 was A$0.00 Mil. Elixinol Wellness received A$0.00 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Elixinol Wellness's net issuance of preferred for the six months ended in Dec. 2023 was A$0.00 Mil. Elixinol Wellness paid A$0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Elixinol Wellness's cash flow for dividends for the six months ended in Dec. 2023 was A$0.00 Mil. Elixinol Wellness received A$0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Elixinol Wellness's other financing for the six months ended in Dec. 2023 was A$0.00 Mil. Elixinol Wellness received A$0.00 Mil on other financial activities.


Elixinol Wellness Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Elixinol Wellness's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Elixinol Wellness (ASX:EXL) Business Description

Traded in Other Exchanges
Address
680 George Street, Level 12, Sydney, NSW, AUS, 2000
Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the geographical segments of the Americas, Australia, Europe and other regions of which key revenue is derived from the Americas segment. The Americas segment includes the trading results of Elixinol LLC (Elixinol Americas) and its investments and joint ventures in the US through the manufacture and distribution of hemp-derived cannabidiol products.

Elixinol Wellness (ASX:EXL) Headlines

No Headlines